Sarah Herzog Memorial Hospital; Ezrat Nashim Association
发明人:
申请号：
EP19200736.7
公开号：
EP3607972A1
申请日:
2014.05.26
申请国别(地区):
EP
年份:
2020
代理人:
摘要：
This invention provides an agent for use in a method of mitigating the severity of, mitigating the pathogenesis of, lowering the incidence of or treating a disease associated with NMDAR antibody production, said method comprising administering the agent, which is an NMDAR agonist, an alanine-serine-cysteine transporter inhibitor, a D-amino acid oxidase inhibitor, a glycine transport inhibitor, D-cycloserine or a combination thereof to a subject.
